During the past decade, Korea Cancer Center Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 12 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Korea Cancer Center Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "GOG Foundation" with 4 trials sponsored, "Samsung Medical Center" with 4 trials sponsored, "Boryung Pharmaceutical Co., Ltd" with 3 trials sponsored and "Asan Medical Center" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Korea Cancer Center Hospital" #1 collaborator was "NRG Oncology" with 8 trials as a collaborator, "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Asan Medical Center" with 3 trials as a collaborator, "Gachon University Gil Medical Center" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Korea Cancer Center Hospital" are "Ovarian Clear Cell Adenocarcinoma" (4 trials), "Recurrent Ovarian Carcinoma" (4 trials), "Cervical Adenocarcinoma" (3 trials), "Diphtheria" (3 trials) and "Endometrial Clear Cell Adenocarcinoma" (3 trials). Many other conditions were trialed in "Korea Cancer Center Hospital" in a lesser frequency.

Most popular intervention types in "Korea Cancer Center Hospital" are "Drug" (33 trials), "Other" (12 trials), "Biological" (11 trials), "Procedure" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (9 trials), "Quality-of-Life Assessment" (9 trials), "Carboplatin" (8 trials), "Laboratory Biomarker Analysis" (6 trials) and "Questionnaire Administration" (5 trials). Other intervention names were less common.

The vast majority of trials in "Korea Cancer Center Hospital" are 25 trials for "All" genders and 19 trials for "Female" genders.

Currently, there are NaN active trials in "Korea Cancer Center Hospital". undefined are not yet recruiting, 3 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Korea Cancer Center Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Korea Cancer Center Hospital, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".